Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Corvus Pharmaceuticals, Inc. (CRVS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Corvus Pharmaceuticals, Inc. (CRVS), most recent 12 months reported: net loss $54.13M, free cash flow -$45.23M. Latest balance sheet on file: liquid cash $215.23M. From SEC filings. Others in Pharmaceutical Preparations: CONTEXT THERAPEUTICS INC. · COCRYSTAL PHARMA, INC. · Cogent Biosciences, Inc. · Corbus Pharmaceuticals Holdings, Inc. · Contineum Therapeutics, Inc. · Citius Oncology, Inc. · Citius Pharmaceuticals, Inc. · Curanex Pharmaceuticals Inc

Stock screener

Watchlist